EVO100
EVO-003
Phase 3 small_molecule completed
Quick answer
EVO100 for Chlamydia Trachomatis Infection is a Phase 3 program (small_molecule) at Evofem Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Evofem Biosciences
- Indication
- Chlamydia Trachomatis Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed